Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Overview of attention for article published in Drugs, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

patent: 8 patents

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 1,306 followers.

RT @DrugsJournal: ARTIMUS-2 phase 3, randomized study of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension p…

ARTIMUS-2 phase 3, randomized study of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension published in the latest issue of @DrugsJournal #glaucoma #Durysta https://t.co/oYrHi6TVWr

New #OpenAccess article published in @DrugsJournal: Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle #Glaucoma and Ocular Hypertension (ARTEMIS 2) https://t.co/KiFoq9EqAy

RT @DrugsJournal: Just published in @DrugsJournal Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.